Currently browsing tag


Sharapova’s peers stunned, but support doping system

By Mark Lamport-Stokes INDIAN WELLS, California (Reuters) – While Maria Sharapova's fellow players were shocked by the Russian's announcement that she failed a drug test at the Australian Open, most of them felt the “huge mistake” could have been avoided. World number three Agnieszka Radwanska of Poland described it as “a very sad day for tennis” but expressed the views of many by saying it was down to every player, via their doctor, to check whether prescribed medications were legal. Five-times grand slam champion Sharapova tested positive for meldonium, which some researchers have linked to increased athletic performance and endurance, after failing by her own admission to realise that it had been outlawed since Jan. 1.

GE seeks sale of asset management arm amid industrial push

GE Asset Management had $115 billion in assets under management as of June 30, according to GE, and manages retirement plans for the vast majority of GE's 136,000 U.S. employees as well as assets for outside institutional investors including third-party retirement plans. The plan to unload the asset management arm comes after GE announced in April it would seek to sell some $200 billion worth of its GE Capital assets as it moves away from financial services and focuses more on manufacturing jet engines, power turbines and other big-ticket industrial equipment. GE Asset Management is separate from GE Capital.